PALOMA MARTINEZ: Open Payments
NPI 1154975662 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 37 payments from 9 companies in 2025. Trend: 2023 $597 · 2024 $442 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $290 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Amgen Inc. | 2 | $47 |
| Blueprint Medicines Corporation | 1 | $17 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Organon LLC | 1 | $13 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, AYVAKIT, NEFFY, EBGLYSS, ALVESCO.
Industry payments across UT — which companies pay providers there.
